Glucose oxidase loaded Cu 2+ based metal-organic framework for glutathione depletion/reactive oxygen species elevation enhanced chemotherapy.
Autor: | Xu J; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Xu Y; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: zhangtong_hmu60@163.com., Sun L; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Lu B; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Yan X; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Wang Z; Department of Thoracic Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China., Zhang T; Department of Radiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: zhangtong_hmu60@163.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Sep; Vol. 141, pp. 111606. Date of Electronic Publication: 2021 Jun 18. |
DOI: | 10.1016/j.biopha.2021.111606 |
Abstrakt: | Introduction: The development of multidrug resistance (MDR) is a major cause for the failure of chemotherapy, which requires the aid of nanomedicine. Methods: Here in our study, a Cu 2+ based metal-organic framework (COF) was firstly developed and employed as a carrier for the delivery of glucose oxidase (GOx) and doxorubicin (Dox) (COF/GOx/Dox) for the therapy of MDR lung cancers. Results: Our results showed that the GOx can catalyze glucose and produce H Discussion: The combination of glutathione depletion/reactive oxygen species elevation might be a promising strategy to enhance the efficacy of chemotherapy and reverse MDR in cancers. (Copyright © 2021. Published by Elsevier Masson SAS.) |
Databáze: | MEDLINE |
Externí odkaz: |